Biodyne Co., Ltd. (KOSDAQ:314930)
South Korea · Delayed Price · Currency is KRW 5,650.00
-20.00 (-0.35%)
At close: Nov 12, 2026
Biodyne Market Cap
Biodyne has a market cap or net worth of 166.54 billion as of November 12, 2026. It is the 23,510th most valuable company in the world and the 902nd biggest in South Korea. Its market cap has decreased by 56.22% in one year.
Market Cap
166.54B
Enterprise Value
151.80B
Revenue
5.77B
Global Rank
Country Rank
#902 South Korea
PE Ratio
138.17
ChartMarket Cap Chart
Since March 17, 2021, Biodyne's market cap has decreased from 252.12B to 166.54B, a decrease of -33.94%. That is a compound annual growth rate of -7.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 166.54B | -58.55% |
| Dec 30, 2025 | 401.82B | -16.15% |
| Dec 30, 2024 | 479.20B | 19.24% |
| Dec 28, 2023 | 401.88B | 185.76% |
| Dec 29, 2022 | 140.63B | -31.74% |
| Dec 30, 2021 | 206.02B | -18.28% |
| Mar 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Curiox Biosystems | 947.90B |
| Livsmed | 832.65B |
| BIOBIJOU | 214.66B |
| Synergy Innovation | 124.76B |
| M.I.TECH Co.,Ltd | 124.12B |
| Celemics | 89.34B |
| Corentec | 64.96B |
| RecensMedical | 51.59B |